Please ensure Javascript is enabled for purposes of website accessibility

Jallal named to UM Health Sciences Research Park board (access required)

Bahija Jallal, Ph.D., executive vice president of research and development at MedImmune, has been named to the board of directors of the UM Health Sciences Research Park Corp. Jallal is a member of MedImmune’s executive team and of the research and development leadership team of parent company AstraZeneca. She oversees research, development, regulatory and clinical activities ...